Business Context and Reporting Period
This Form 8-K is a current report filed by Inpixon (trading symbol: INPX) on October 31, 2019. The filing details a material definitive agreement entered into on the same date between the Company and Iliad Research and Trading, L.P. ("Iliad"), a holder of the Company's outstanding promissory notes.
Key Financial Metrics and Transaction Details
- Debt Reduction: The Company reduced its outstanding debt by $240,000 through the partitioning and exchange of a portion of a promissory note originally issued on December 21, 2018.
- Equity Issuance: The Company issued 3,000,000 shares of common stock to Iliad at an effective price of $0.10 per share.
- Outstanding Debt (as of Oct 9-31, 2019):
- Iliad held a note issued September 17, 2019, with a balance of approximately $0.958 million.
- Chicago Venture Partners, L.P. (an affiliate of Iliad) held notes with an aggregate balance of approximately $8.014 million.
- The Original Note held by Iliad had a balance of $1,724,760.29 prior to the $240,000 reduction.
- Capital Structure (as of Oct 31, 2019):
- Common Stock Outstanding: 66,314,768 shares (inclusive of the new issuance).
- Series 4 Convertible Preferred Stock: 1 share (convertible into 202 common shares).
- Series 5 Convertible Preferred Stock: 126 shares (convertible into approx. 37,838 common shares).
- Warrants Outstanding: 112,800 shares (exercise price $3.33) and 213,700 shares (exercise price $0.2775).
Note: This filing does not provide revenue, profit, cash flow, or margin data.
Material Changes
The primary material change is the conversion of $240,000 of debt into equity. This transaction reduces the Company's interest-bearing liabilities and increases the number of outstanding common shares by 3,000,000. The shares were issued unregistered under Section 3(a)(9) of the Securities Act of 1933 as an exchange of securities without additional consideration.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the summary of the exchange agreement is not complete and is qualified by the full text of the agreement filed as Exhibit 10.1. The transaction is contingent upon the delivery of shares to Iliad on or before November 1, 2019, and the surrender of the partitioned note upon approval by Iliad's brokerage firm.
Investor Verification Checklist
- Verify the total outstanding debt obligations, specifically the $8.014 million held by Chicago Venture Partners and the remaining balance of the Iliad notes.
- Confirm the dilution impact of the 3,000,000 new shares on existing shareholders.
- Review the full text of the Exchange Agreement (Exhibit 10.1) for covenants or conditions not summarized in the 8-K.
- Assess the liquidity position given the significant debt load relative to the equity raised in this specific transaction.